Дата випуску | Назва | Автор(и) |
2017 | Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats | Kobyliak, N.; Virchenko, O.; Falalyeyeva, T.; Kondro, M.; Beregova, T.; Ostapchenko, L.; Bodnar, P.; Shcherbakov, O.; Bubnov, R.; Caprnda, M.; Delev, D.; Sabo, J.; Kruzliak, P.; Rodrigo, L.; Opatrilova, R.; Spivak, M. |
2019 | Crosstalk between gut microbiota and antidiabetic drug action | Kyriachenko, Y.; Falalyeyeva, T.; Korotkyi, O.; Molochek, N.; Kobyliak, N. |
2024 | Early diagnosis of mineral and bone disorders in patients with diabetic kidney disease on the background of type 2 diabetes | Yerokhovych, V.; Karpenko, O.; Paliienko, I.; Kobyliak, N.; Bobryk, M.; Shuliarenko, L.; Rudenko, O.; Kyriienko, D.; Bolanowski, M.; Komisarenko, Y. |
2022-03 | Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment | Manzhalii, E.; Moyseyenko, V.; Kondratiuk, V.; Molochek, N.; Falalyeyeva, T.; Kobyliak, N. |
2018-09 | Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial. | Kobyliak, N.; Falalyeyeva, T.; Mykhalchyshyn, G.; Kyriienko, D.; Komisarenko, I. |
2019-05 | Effect of probiotic on serum cytokines and matrix metalloproteinases profiles during monoiodoacetate-induced osteoarthritis in rats | Korotkyi, O.; Vovk, A.; Galenova, T.; Vovk, T.; Dvorschenko, K.; Luzza, F.; Abenavoli, L.; Kobyliak, N.; Falalyeyeva, T.; Ostapchenko, L. |
2018-02 | Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease | Kobyliak, N.; Abenavoli, L.; Falalyeyeva, T.; Beregova, T. |
2023 | Level of IL-6 and IL-8 and their associations with non-alcoholic fatty liver disease in patients with type 2 diabetes | Mykhalchyshyn, G.; Kobyliak, N.; Komisarenko, I. |
2019-01 | Neuropathic diabetic foot ulcers treated with cerium dioxide nanoparticles: A case report | Kobyliak, N.; Abenavoli, L.; Kononenko, L.; Kyriienko, D.; Spivak, M. |
2018-10 | Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease | Abenavoli, L.; Falalyeyeva, T.; Boccuto, L.; Tsyryuk, O.; Kobyliak, N. |
2018 | Polyphenol Compounds Melanin Prevented Hepatic Inflammation in Rats with Experimental Obesity | Belemets, N.; Kobyliak, N.; Falalyeyeva, T.; Kuryk, O.; Sulaieva, O.; Vovk, T.; Beregova, T.; Ostapchenko, L. |
2018-07 | Probiotics and nutraceuticals as a new frontier in obesity prevention and management | Kobyliak, N.; Falalyeyeva, T.; Boyko, N.; Tsyryuk, O.; Beregova, T.; Ostapchenko, L. |
2019-09 | Probiotics and smectite absorbent gel formulation reduce liver stiffness, transaminases and cytokine levels in NAFLD associated with type 2 diabetes: a randomized clinical study | Kobyliak, N.; Abenavoli, L.; Mykhalchyshyn, G.; Falalyeyeva, T.; Tsyryuk, O.; Kyriienko, D.; Kononenko, L.; Komisarenko, I. |
2022-06 | Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter? | Ryspayeva, D.; Halytskiy, V.; Kobyliak, N.; Dosenko, I.; Fedosov, A.; Inomistova, M.; Drevytska, T.; Gurianov, V.; Sulaieva, O. |
2022 | Resveratrol Effects on the Reproductive System in Ovariectomized Rats: Deciphering Possible Mechanisms | Zaychenko, G.; Stryga, O.; Sinitsyna, O.; Doroshenko, A.; Sulaieva, O.; Falalyeyeva, T.; Kobyliak, N. |
2018-04 | The correction of the metabolic parameters of msg-induced obesity in rats by 2-[4-(benzyloxy) phenoxy] acetic acid | Konopelniuk, V.; Falalyeyeva, T.; Tsyryuk, O.; Savchenko, Y.; Prybytko, I.; Kobyliak, N.; Kovalchuk, O.; Boyko, A.; Arkhipov, V.; Moroz, Y.; Ostapchenko, L. |
2018 | The effects of Z56822977 on biosynthesis of serotonin in the brain of rats in the conditions of MSG-induced obesity | Konopelniuk, V.; Falalyeyeva, T.; Tsyryuk, O.; Savchenko, Y.; Kobyliak, N.; Prybytko, I.; Kovalchuk, O.; Boyko, A.; Arkhipov, V.; Moroz, Y.; Ostapchenko, L. |
2018-06 | The role of Nanotechnology in food safety | Colica, C.; Aiello, V.; Boccuto, L.; Kobyliak, N.; Strongoli, M.; Vecchio, I.; Abenavoli, L. |